Every article on The Fenbendazole is researched, written, and edited to the same standard: claims are traced to their primary source, uncertainty is stated plainly, and nothing is dressed up as medical advice.
Daniel Brooks
Daniel Brooks is an independent health researcher and investigative writer. He founded The Fenbendazole to collect, verify, and explain the fast-growing body of research and anecdote around fenbendazole and other repurposed anticancer compounds — without the hype that surrounds the topic elsewhere.
His work focuses on reading the underlying studies rather than repeating headlines: separating preclinical (cell and animal) findings from human evidence, flagging where data is thin or absent, and putting individual case reports in their proper context. He also leads the site's independent product reviews, which rate fenbendazole brands on purity, dosing accuracy, and honest labeling.
Read all articles by Daniel Brooks →
Our Editorial Standards
- Sourced claims. Scientific statements link to peer-reviewed studies or official documents wherever possible.
- Honest framing. We state clearly that fenbendazole is not FDA-approved for cancer and that there are no completed human randomized controlled trials for that use.
- Independence. Product reviews are not pay-to-play; ratings reflect our own analysis.
- Plain language. Complex pharmacology is explained so non-specialists can follow it.
Questions, corrections, or research you think we should cover? Learn more about this project or reach us through our contact page.
Educational information only. Nothing here is medical advice. Always consult a qualified healthcare professional before making treatment decisions.
